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Various lectins were tested for blocking rotavirus infection of MA104 cells and it was observed that galactose-specific
lectins were the most inhibitory. Of these Ricinus agglutinin was able to inhibit infection (by human and animal strains) at
concentrations as low as 1029 M. In addition, in a virus overlay protein blot assay Ricinus agglutinin competed with simian
rotavirus SA11 for binding to solubilized MA104 proteins. Amino acid sequence comparisons revealed similarity between the
ricin toxin B subunit (which contains two separate carbohydrate-binding motifs: single binding domains (SBD) 1 and 2) and
rotavirus spike protein VP4. A filamentous phage display system was used to independently express the two binding domains
and while SBD1 inhibited infection of MA104 cells by CRW8, NCDV, and to a lesser extent Wa, SBD2 blocked only CRW8 and
NCDV infection. Furthermore inhibition of CRW8 infection was a direct result of phage inhibiting virus attachment to cells.
When amino acid 248 within SBD2 was mutated from the ricin toxin to the Ricinus agglutinin sequence this phage clone
showed reduced binding to galactose and was no longer able to inhibit virus infection. Thus, rotavirus recognizes galactose
as an important component of the receptor on MA104 cells. © 2000 Academic Press
Key Words: rotavirus; VP4; receptor; MA104; galactose; lectin; ricin; phage display.
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1INTRODUCTION
Rotaviruses are recognized as the leading cause of
acute viral gastroenteritis in newborn humans and ani-
mals, causing nearly one million human deaths annually
(Hoshino and Kapikian, 1994), mainly in developing coun-
tries. Particles of rotavirus (a member of the family Reo-
viridae) are triple layered with the outer capsid com-
posed of two proteins, VP4 and VP7, which dictate the P
and G serotypes, respectively, and both elicit neutralizing
antibody (Greenberg et al., 1983b; Hoshino et al., 1985).
The dimeric VP4 protrudes as spikes from the virion
surface (Prasad et al., 1988) and is associated with
virulence (Bridger et al., 1998; Burke et al., 1994a and b;
Offit et al., 1986; Tauscher and Desselberger, 1997) and
restriction of virus growth in cell culture (Greenberg et
al., 1983a). Proteolytic cleavage of VP4 by trypsin pro-
duces VP5* and VP8* and is required to enhance viral
infectivity (Espejo et al., 1981; Estes et al., 1981), specif-
ically penetration (Clark et al., 1981; Fukuhara et al., 1988;
Kaljot et al., 1988). The smaller cleavage product VP8*
ontains the hemagglutinating domain (Fiore et al., 1991;
uentes Panana et al., 1995; Kalica et al., 1983) while
VP5* has a putative fusion region spanning amino acids
384–401 (Mackow et al., 1988). Despite early work impli-
ating VP7 (Fukuhara et al., 1988; Sabara et al., 1985),
1 To whom correspondence and reprint requests should be ad-S
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89studies have since supported VP4 as the viral attach-
ment protein. Monoclonal antibodies to VP4 are more
efficient inhibitors of viral attachment than antibodies to
VP7 (Ruggeri and Greenberg, 1991) while expressed VP4
adheres to brush border membranes and competes with
whole virus for cell attachment (Bass et al., 1991). Fur-
hermore in experiments with virus-like particles the
resence of VP4 was found to be essential for binding to
A104 cells (Crawford et al., 1994). Within VP4, specific
esidues that can alter the receptor specificity of rotavi-
us strains have been identified (Mendez et al., 1993) and
lysine at 187 within VP8* appears to have particular
mportance (Ludert et al., 1998).
Unfortunately, the cellular receptor for rotavirus is not
s clearly defined; however, while many animal strains
equire sialic acid for infection, human strains do not
Fukudome et al., 1989). In addition, although there is
vidence that the type of sialic acid and the specific
inkages preferred by different strains vary (Fukudome et
l., 1989; Willoughby and Yolken, 1990; Yolken et al.,
987), knowledge of how this is related to receptor utili-
ation is lacking. Early work has implicated glycoproteins
s the cellular receptor (Yolken et al., 1987; Willoughby
nd Yolken, 1990; Willoughby, 1993); however, recent
tudies have identified glycolipids (Rolsma et al., 1994,
998; Srnka et al., 1992; Superti and Donelli, 1991). Sim-
ilarly, despite the well-documented preference for sialic
acid glycans there is evidence that some rotaviruses can
bind their asialo derivatives (Willoughby et al., 1990;
rnka et al., 1992) and recently integrin ligand-binding
0042-6822/00 $35.00
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90 JOLLY, BEISNER, AND HOLMESmotifs have been identified within VP4 and VP7, implicat-
ing a role for these proteins in rotavirus infection (Coul-
son et al., 1997). Clearly, further work on rotavirus recep-
ors is required.
In this paper we used lectins to compare the carbo-
ydrate requirement of human, simian, porcine, and bo-
ine strains and demonstrated that rotavirus specifically
ecognizes galactose as an important component of the
ellular receptor.
RESULTS
Galactose-specific lectins inhibit rotavirus infection
A lectin panel that encompassed, as ligands, a num-
ber of common carbohydrates and linkages was tested
for rotavirus inhibition and it was observed that low
concentrations of the galactose-specific lectins from Ric-
inus communis, Abrus precatorius, and Viscum album
were able to inhibit bovine strain NCDV infection (Table
1). As Ricinus agglutinin was such a potent inhibitor we
extended our experiments and demonstrated that this
lectin was also able to inhibit human Wa, simian SA11,
and porcine CRW8 infection and that blocking did not
TABLE 1
Rotavirus Strain NCDV Infection of MA104 Cells Is Inhibited
by Galactose-Specific Lectins
Lectin from Sugar specificity IC50 mg/ml
a
Abrus precatorius b-D-Gal 1.9 3 1022
Arachis hypogaea b-D-Gal(1-3)-D-GalNAc .40
rtocarpus integrifolia a-Gal and b-D-Gal(1-3)-D-
GalNAc
20
Bauhinia purpurea D-GalNAc .40
Datura stramonium (D-GlcNAc)2 .40
Glycine max D-GalNAc .40
Limax flavus NeuNAc .40
Limulus polyphemus NeuNAc 10–20
Maackia amurensis NeuNAc-a(2,3)-Gal .40
aclura pomifera a-D-Gal .40
omordica charantia D-Gal, D-GalNAc .40
icinus communis
(RCA120)
b-D-Gal 6 3 1024
Sambucus nigra NeuNAc-(2,6)-Gal .40
Sophora japonica b-D-GalNAc .40
ridacna maxima b-D-Gal .40
riticum vulgaris (D-GlcNAc)2, NeuNAc .40
iscum album D-Gal, D-GalNAc 7.8 3 1022
Note. MA104 cells were treated with lectins for 15 min at 4°C
followed by the addition of virus for a further hour at 4°C. The lectin–
virus mix was removed and replaced with maintenance medium and
cells were incubated overnight at 37°C in 5% CO2. Virus-infected cells
ere detected by indirect immunofluorescence.
a Minimum concentration of lectin required to inhibit NCDV infection
y 50%. The sugar specificities were provided by the lectin suppliers
nd the sugars are defined as follows: NeuNAc, N-acetyl neuraminic
cid; GlcNAc, N-acetyl-D-glucosamine; Glc, glucose; Gal, galactose;
GalNAc, N-acetyl-D-galactosamine.
p
ocorrelate with viral P or G type (Table 2). Total inhibition
of NCDV, CRW8, SA11, and Wa infection of MA104 cells
was observed with Ricinus agglutinin lectin at concen-
trations ranging from 0.009 to 0.312 mg/ml depending on
the viral strain, and by preincubating Ricinus lectin with
0.1 M galactose we could completely abolish inhibition of
NCDV infection (data not shown). To confirm that the
inhibitory activity was not due to cellular toxicity of the
lectin we tested Ricinus agglutinin against influenza vi-
rus strains Mem71H-BelN(H3N1) and A/Brazil/11/78
(H1N1). Infection of MA104 cells by the Brazil strain was
reduced by 50% with 0.31 mg/ml of lectin while for
em71H-BelN inhibition was not evident even at concen-
rations as high as 10 mg/ml.
Inhibition of rotavirus infection of MA104 cells in the
presence of Ricinus agglutinin was assumed to be the
result of the lectin interacting directly with a rotavirus
cellular receptor. To confirm this, a series of virus overlay
protein blot assays (VOPBAs) was performed (Fig. 1).
TABLE 2
Ricinus Agglutinin Inhibits NCDV, CRW8, SA11, and
Wa Infection of MA104 Cells
Strain Serotype IC50 mg/ml
a
NCDVb P6[1] G6 6.0 3 1023 mg/ml
CRW8 P9[7] G3 4.4 3 1023 mg/ml
SA11 P5B[2] G3 6.8 3 1022mg/ml
Wa P1A[8] G1 2.8 3 1022 mg/ml
Note. MA104 cells were treated with lectin for 15 min at 4°C followed
by the addition of virus for a further hour at 4°C. The lectin–virus mix
was removed and replaced with maintenance medium, and cells were
incubated overnight. Virus-infected cells were detected by indirect
immunofluorescence.
a Minimum concentration of lectin required to inhibit infection by
0%.
b Inhibition of infection was abolished by preincubating the lectin
with 0.1 M galactose.
FIG. 1. VOPBAs of rotavirus binding to Triton X-100 solubilized MA104
cell extracts. Cell extracts were separated on a 10% polyacrylamide gel,
transferred to nitrocellulose, and probed with 3–5 mg/ml of purified
A11 (A), NCDV (B), Wa (C), and CRW8 (D) virus to visualize virus-
inding proteins. Bound virus was detected with specific antisera as
escribed under Materials and Methods and color development was
ith 4-chloro-1-napthol and diaminobenzidine. Control blots were also
erformed and were incubated separately either without virus or with-
ut antisera (not shown).
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91GALACTOSE AND ROTAVIRUS RECEPTORSRotavirus strains NCDV and SA11 both recognize three
apparently common MA104 cellular components be-
tween 66 and 97 kDa while CRW8 recognizes two of
these (the intermediate band appears to be absent). The
human strain Wa is able to recognize only the interme-
diate component that is evident in the SA11 and NCDV
blots but is absent in the CRW8 overlay. When SA11 was
incubated in conjunction with Ricinus agglutinin (Fig. 2)
inding of virus to the two higher molecular weight pro-
eins was abolished, indicating that SA11 interacts with
hese proteins through recognition of a galactose moiety.
xpression of single binding domain 1 (SBD1) and
ingle binding domain 2 (SBD2) in a filamentous
hage display system
When a VP4 gene-targeted filamentous phage display
ibrary was panned over MA104 cell monolayers, a num-
er of cell-binding phage were selected (manuscript in
reparation), and of these, two independently isolated
lones contained VP4 insert sequences that displayed
equence similarity to the Ricinus lectin. Specifically,
these phage identified a conserved region within VP5*
(aa 406–416 and 466–476) that has similarity to the li-
gand-binding B subunit of Ricinus agglutinin and ricin
toxin (aa 113–123 and 102–112) (Fig. 3). This similarity is
close to SBD1, one of the two galactose-binding do-
mains, and it was of interest to determine whether both
SBD1 and SBD2 would inhibit virus infection or whether
inhibition was restricted to SBD1 whose environs resem-
bled VP5*. To address this both SBD1 and SBD2 of the
ricin toxin were independently expressed in the filamen-
tous bacteriophage fd-tet and shown to be active by
ELISA (Fig. 4). The specificity of binding to asialofetuin
FIG. 2. Solubilized MA104 cell proteins were separated on a 10%
polyacrylamide gel and transferred to nitrocellulose, and the mem-
brane was blocked in 5% gelatin. The blot was probed with 5 mg/ml
purified SA11 alone (A) or SA11 with 15 mg/ml Ricinus agglutinin (B) and
bound virus was detected using anti-SA11 serum followed by HRP-
conjugated anti-rabbit antibody. Color development was performed
using 4-chloro-1-napthol and diaminobenzidine. For determination of
the relative molecular masses SeeBlue prestained markers (kDa) are
shown and the cellular components that are no longer bound by SA11
in the presence of Ricinus are indicated with arrows.was confirmed by using wild-type phage without a gene
3 insert as a negative control.
l
wSBD1 and SBD2 block rotavirus infection of MA104 cells
Earlier data showed that different strains of rotavirus
varied in their sensitivity to Ricinus agglutinin and this
was also observed for SBD1 and SBD2 phage (Fig. 5).
SBD1 phage was able to inhibit infection of CRW8 by
58%, NCDV by 41%, and Wa by 25%; interestingly there
was no inhibition of SA11. Similarly, SBD2 phage was
also able to reduce CRW8 and NCDV infection (by 51 and
49%, respectively); however, there was no effect against
either SA11 or Wa. Maximum inhibition of CRW8, NCDV,
and Wa occurred at 20 nM and increasing the concen-
tration of phage to 160 nM did not enhance the effect.
Also the inhibition of virus infection by SBD1 and SBD2
phage was not additive (data not shown), indicating that
SBD1 and SBD2 phage are inhibiting virus via the same
mechanism. To determine whether the inhibition of
CRW8 and NCDV was due to phage blocking virus at-
tachment, or a postattachment infection step, a binding
assay was performed (Fig. 6). SBD1 and SBD2 de-
creased CRW8 binding to MA104 cells by 75 and 60%,
respectively; however, for NCDV, while SBD1 caused a
slight decrease (22%), SBD2 was unable to significantly
affect binding.
FIG. 4. Galactose-binding activity of Ricinus agglutinin (A) and SBD1,
BD2, and SBD2 his248 phage (B). (A) Ricinus agglutinin (n ) and lectin
reincubated with 100 mM galactose (}) were included as controls. (B)
he activity of recombinant phage expressing SBD1 (n ), SBD2 (}),
BD2 his248 (E), or that of wild-type phage without a gene 3 insert (F)
as tested by binding to asialofetuin in an ELISA. Each concentration
f phage was assayed in triplicate and the standard error was calcu-
FIG. 3. Alignment of ricin toxin B subunit (amino acids 102–123) with
rotavirus VP4 (amino acids 466–477 and 406–416). Ricinus agglutinin
has a sequence similar to that of ricin within this region except residue
104 encodes a glycine and residue 117 a lysine. The sequences of ricin
and Ricinus agglutinin were obtained from Roberts et al. (1985), and
those of rotavirus are from Huang et al. (1993) and Estes and Cohen
(1989).ated, experiments were performed three times, and similar results
ere obtained.
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92 JOLLY, BEISNER, AND HOLMESSBD2 inhibition of rotavirus infection is mediated by a
tyrosine residue at 248
A comparison of the amino acid sequences of the B
subunit of ricin toxin and Ricinus agglutinin lectin reveals
that amino acid differences are present within both SBD1
and SBD2 (Roberts et al., 1985). It has been documented
that SBD2 of the agglutinin no longer possesses galac-
tose-binding activity (Rutenber and Robertus, 1991) and
this loss of function has been mapped to residue 248.
While the toxin sequence encodes a tyrosine at 248, the
agglutinin sequence encodes a histidine and this ty-
rosine residue is proposed to be crucial in the formation
of the correct interactions with carbohydrate. Mutation of
the toxin sequence from a tyrosine to a histidine has
been observed to abolish galactose binding (Sphyris et
al., 1995) and here we generated such a mutant phage,
designated SBD2His248. This mutant was confirmed to
have a histidine at 248 by sequence analysis while all
FIG. 5. Inhibition of virus infection of MA104 cells by SBD1 (A) and
SBD2 (B) phage. Cells were treated with phage for an hour at 4°C prior
to the addition of virus for a further hour. The phage–virus mix was
removed and replaced with maintenance medium and cells were in-
cubated overnight. Virus-infected cells were detected by indirect im-
munofluorescence. Percentage infection for CRW8 (n ), NCDV (}), SA11
(F), and Wa (h) was determined by comparison to virus infection in the
absence of phage. Each virus was assayed in triplicate, experiments
were performed three times, and the standard error was calculated.
FIG. 6. Inhibition of CRW8 (A) and NCDV (B) binding to MA104 cells
by SBD1 and SBD2 phage. Cells were treated with phage for an hour
at 4°C prior to the addition of virus for a further hour. Unbound
phage–virus mixtures were removed and cells were washed in PBS (all
buffers were ice-cold). Monolayers were freeze–thawed twice and
lysates were activated with porcine trypsin. Virus was then titrated in a
standard infectivity assay. Percentage infection of CRW8 and NCDV
was determined by comparison to non-phage-treated cells (as shownc
t
in A and B). Each virus was assayed in triplicate, experiments were
performed three times, and the standard error was calculated.other residues were identical to the original SBD2 clone.
SBD2His248 had reduced binding to asialofetuin as
measured by ELISA (Fig. 4) and was unable to inhibit
rotavirus infection of MA104 cells (Fig. 7).
DISCUSSION
In an attempt to characterize the cellular receptor for
rotavirus a number of lectins were tested for their ability
to inhibit bovine rotavirus strain NCDV infection of
MA104 cells. The galactose-binding Ricinus lectin was
the most inhibitory and this inhibition was shown to be
sugar specific by preincubating the lectin with galactose,
its natural ligand. Furthermore, influenza virus was able
to infect cells in the presence of Ricinus agglutinin at
concentrations that were inhibitory to rotavirus, proving
that rotavirus inhibition was not due to an abrogation of
normal cell function. Previously Superti and Donelli
(1991) had also found that Ricinus lectin was able to
block rotavirus infection; however, we observed the con-
centration of lectin used in that study to be far above the
level that was toxic to cells in our system. R. communis
contains two lectins, an agglutinin and a toxin, that have
evolutionary relatedness and display 84% amino acid
homology within the galactose-binding B chain (Roberts
et al., 1985). The carbohydrate specificities of these two
lectins have been extensively studied (Nicolson et al.,
1975; Baenziger and Fiete, 1979). The agglutinin and the
toxin both recognize b1-3- and b1-4-linked galactose on
omplex oligosaccharides as well as sialylated galac-
ose, but only if the sialyl linkage is a2-6. In addition there
is some evidence that the toxin can also recognize ga-
lactose containing an a2-3-linked sialic acid; however,
his is dependent on the underlying carbohydrate se-
uence (Green et al., 1987). Furthermore, while the toxin
FIG. 7. Inhibition of virus infection of MA104 cells by SBD2His248
phage. Cells were treated with phage for an hour at 4°C prior to the
addition of virus for a further hour. The phage–virus mix was removed
and replaced with maintenance medium and cells were incubated
overnight. Virus-infected cells were detected by indirect immunofluo-
rescence. Percentage infection for CRW8 (n ), NCDV (}), SA11 (F), and
Wa (h) was determined by comparison to virus infection in the absence
of phage. Each virus was assayed in duplicate and the standard error
calculated. A representative experiment is shown.an bind to terminal N-acetyl-galactosamine (via SBD2),
he agglutinin cannot; this finding combined with the fact
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93GALACTOSE AND ROTAVIRUS RECEPTORSthat the agglutinin binds only two galactose molecules
and not four has been interpreted to indicate that the
agglutinin has lost activity in the second binding domain
(Rutenber and Robertus, 1991). Sequence comparisons
and site-directed mutagenesis have demonstrated di-
rectly that it is the presence of His-248 in the Ricinus
agglutinin, compared to Tyr-248 in the toxin, that inter-
feres with galactose binding in the second domain of the
agglutinin (Lehar et al., 1994; Sphyris et al., 1995). The
other galactose-specific lectins from Abrus and Viscum
also showed inhibitory activity against rotavirus although
the effect was reduced compared to that of Ricinus. This
is probably due to slight differences in the galactose
linkage specificity. Abrus lectin, unlike Ricinus, prefers
Galb1-3GalNac and does not react well with sialylated
alactose (Wu et al., 1992), while Viscum lectin will bind
to galactose and sialylated galactose (Franz et al., 1981);
owever, it can also interact with D-GalNAc. The lectins
rom Momordica and Tridacna are also proposed to bind
alactose but there are few data available on the exact
pecificity of these. Momordica charantia lectin binds to
-acetyl-galactosamine and galactose; however, it can-
ot interact with sialylated galactose (Mazumder et al.,
981). In addition there is evidence that this lectin may
ontain a subsite capable of binding glucose (Mazumder
t al., 1981). As for the lectin Tridacnin, it recognizes
b-D-galactose; however, unlike Ricinus and other galac-
tose-specific lectins, it reacts poorly with asialofetuin
(Uhlenbruck et al., 1977). Therefore it is hardly surprising
that these lectins gave different results from Abrus, Vis-
cum, and Ricinus.
NCDV infection is sensitive to neuraminidase treat-
ment of cells (Fukudome et al., 1989) so it was surprising
that neither of the sialic acid-specific lectins from Sam-
bucus nigra and Maackia amurensis inhibited NCDV. We
think that the inability of the sialic acid-specific lectins to
block infection may be due to failure to achieve saturat-
ing concentrations with these lectins or to the virus
having a higher affinity than the lectins for the cellular
receptor. Furthermore, perhaps the virus interacts mainly
with the galactose moiety but the a2,6-linked sialic acid
is required to hold the galactose in a particular orienta-
tion for binding, and as a result the sialic acid-specific
lectins do not block. At this point the possible contribu-
tion of steric hindrance should be addressed. It is always
possible that the observed inhibition by Ricinus aggluti-
nin could be a result of the lectin interacting with a
galactose residue adjacent to the actual glycan recog-
nized by rotavirus, and as such, steric hindrance cannot
be ruled out. However, we believe the evidence that only
the galactose-specific lectins are able to inhibit rotavirus
infection and not lectins specific for other carbohydrates
that could also be present adjacent to virus-binding sites
means that steric effects cannot adequately explain our
results.
To further examine the role of galactose in rotavirusinfection and to help elucidate the relevant regions of
VP4 involved in galactose binding we examined SBD1
and SBD2 separately using phage display. As mentioned,
there is doubt about the activity of SBD2 in Ricinus
agglutinin and for this reason we chose to use the ricin
toxin B subunit for expression of SBD1 and SBD2 in
phage. Data obtained with these recombinant phage
revealed that although infection of both CRW8 and NCDV
was inhibited, only CRW8 displayed a marked abrogation
of binding. Specifically, CRW8 appears to utilize galac-
tose for binding to the cellular receptor while bovine
NCDV requires galactose for a postbinding entry step.
Simian SA11 was not inhibited by SBD1 or SBD2 and was
affected like human Wa in blocking by Ricinus lectin and
by recombinant phage. One possible explanation for the
inability of the recombinant phage to inhibit SA11 and Wa
infection is the affinity of the interactions. The Ricinus
agglutinin is a dimeric molecule with high affinity for
galactose residues but was less effective at inhibiting
SA11 and Wa than NCDV and CRW8, which were both
blocked by SBD1 and SBD2. Unfortunately we were un-
able to reverse the effects of SBD1 and SBD2 by prein-
cubating the phage with galactose and this is not unex-
pected as it is well documented that when expressed in
a nonglycosylating system like bacteria, ricin is unable to
interact with single sugars; however, it can still recognize
complex oligosaccharides (Richardson et al., 1991). We
also attempted to use recombinant phage to compete
with virus for binding to MA104 cell proteins in a VOPBA
similar to that performed with whole lectin and SA11;
however, this was unsuccessful. Even at the highest
concentration of phage tested, bound virus could still be
detected (data not shown), which is not surprising as we
were also unable to completely abolish virus attachment
in our binding assays.
As it is established that a change from Tyr-248 to
His-248 within SBD2 is responsible for the loss of galac-
tose binding of SBD2, we used site-directed mutagene-
sis to create a SBD2 clone in which residue 248 was
changed from an active binding domain (tyrosine) to an
inactive domain (histidine). This served to alter the se-
quence from toxin-like to agglutinin-like as well as to
provide a control to demonstrate that the inhibition by
these phage clones was specific. The mutant phage
clone SBD2His248 had a 50% reduction in galactose
binding compared to the nonmutated SBD2. Importantly
this phage was no longer able to inhibit rotavirus infec-
tion, demonstrating that the inhibition of rotavirus by
phage expressing ricin toxin clones is specific. Further-
more these data intimate that the complete Ricinus ag-
glutinin lectin is inhibiting virus infection via SBD1, not
SBD2, because when we mutated SBD2 from the toxin to
the agglutinin sequence (SBD2His248) we lost inhibitory
activity.Within VP4 the hemagglutinating region has been lo-
calized to aa 98–203 (Fiore et al., 1991; Kalica et al., 1983)
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94 JOLLY, BEISNER, AND HOLMESin VP8* and there is evidence that the sialic acid-binding
domain also lies within this region (Ludert et al., 1998;
Mendez et al., 1996). It is tempting to propose that amino
acids 406–416 and 466–476 within VP5*, which showed
homology to ricin, may also be involved in infection.
Filamentous phage clones displaying these regions of
VP4 were specifically selected by panning a VP4 gene-
targeted library over MA104 cells (manuscript in prepa-
ration) and while both 406–416 and 466–476 are highly
conserved among rotavirus strains, amino acids 406–416
are also adjacent to the putative fusion sequence (aa
384–401). Mutations within this region at residue 469
have been associated with the emergence of pathoge-
nicity in piglets (Burke et al., 1994a) and changes at
adjacent sites are associated with the adaptation of virus
growth in cell culture (Kirkwood et al., 1998). Based on
the differences presented here between strains it is
unclear whether this conserved site would be utilized by
all rotaviruses. Our preliminary experiments indicate that
this region may be involved in recognition of MA104 cell
surface proteins; however, further work with peptides or
expressed mutant VP4 or VP5* protein is needed to
address this.
Despite numerous studies the cellular receptors for
rotavirus are ill defined. While sialic acid-dependent and
-independent groups of strains have been identified, the
specific structure or cell surface molecule serving as the
receptor/s has not been identified. A number of detailed
studies by Rolsma et al. (1994, 1998) have begun to
elucidate the in vivo receptor structures recognized by
porcine strain OSU and this is particularly relevant as
CRW8 and OSU share 97% VP4 amino acid homology
(Huang et al., 1993). OSU was shown to interact in a
sialic acid-dependent manner with a ganglioside fraction
from porcine enterocytes (Rolsma et al., 1994, 1998) and
this fraction contained both N-acetyl and N-glycolyl
neuraminic acids. The relative importance of N-acetyl
versus N-glycoyl is not established; however, the latter is
he form identified in a normal mouse serum inhibitor
hat showed activity against CRW8 among others (Beis-
er et al., 1998). The sialic acid-dependent nature of OSU
infection has also been demonstrated in studies using
mutant CHO cell lines that are altered in their glycosyl-
ation (Rolsma et al., 1998). We have found that CRW8, like
SU, infects in a sialic acid-dependent manner as de-
ermined by neuraminidase treatment (unpublished
ata); however, we do not know yet whether infection
nvolves a glycoprotein or glycolipid. While studies of this
ature using bovine strains such as NCDV are lacking,
urther work characterizing the cellular receptor for OSU
hould provide valuable clues about potential receptor
tructures for CRW8.
A large proportion of studies to date have used the
imian strain SA11 and like most animal rotaviruses
A11 requires sialic acid for infection (Yolken et al., 1987;
ukudome et al., 1989; Willoughby, 1993; Superti andDonelli, 1995); however, it can also interact with asialo
structures (Srnka et al., 1992; Willoughby et al., 1990).
Conversely, human strain Wa is sialic acid independent
but curiously neutralization of infection by murine a1-
antitrypsin was shown to be dependent on sialic acid
(Beisner et al., 1998). Recently integrin ligand-binding
motifs have been identified within VP4 of most strains of
rotavirus, and peptides containing these motifs are able
to inhibit SA11 and human strain RV-5 infection (Coulson
et al., 1997). Furthermore a direct interaction between
SA11 rotavirus particles and integrins has been demon-
strated (S. Londrigan, personal communication); how-
ever, the observed molecular weights of the integrins
implicated in rotavirus infection do not correlate with the
cellular components identified in this study. Taken to-
gether these data indicate that rotavirus may utilize two
receptor molecules during infection. Thus we agree with
a previous hypothesis (Mendez et al., 1993, 1999) that
rotavirus interacts with a sialic acid-containing receptor
prior to a second interaction with a sialic acid-indepen-
dent receptor and subsequent membrane fusion. This
possibly occurs via a mechanism similar to the dual-
receptor conformational change that is proposed for HIV
(Kwong et al., 1998; Moore et al., 1992; Truneh et al.,
1991). Although a direct binding interaction between
CRW8 and galactose is not shown, one explanation may
be that CRW8 binds to sialic acid and galactose moieties
when attaching to the cellular receptor while NCDV uti-
lizes sialic acid for initial binding and galactose during a
subsequent binding step or during infection. These vi-
ruses may then undergo a secondary interaction with a
sialic acid-independent receptor during the infection pro-
cess. Whether this secondary interaction involves the
same receptor as that used by sialic acid-independent
strains is yet to be determined. In the case of SA11 there
are some conflicting data about whether or not this virus
requires sialic acid. It is possible that SA11 also interacts
with a sialylated molecule prior to binding a sialic acid-
independent receptor, possibly an integrin; however, in
this study we found that SA11 behaved similarly to Wa
and displayed a receptor specificity that was quite dif-
ferent from the other animal strains tested. Perhaps SA11
is able to use a nonsialylated receptor exclusively when
the carbohydrate-containing receptor is not available;
this may be the same molecule used by human strains or
a novel receptor.
Previously most work on the cellular receptor for rota-
virus has used one strain and extrapolated to others; in
this paper we have shown this is not possible. Clearly
different strains of rotavirus can have quite different
cellular receptor specificities, even within the sialic acid-
dependent group, and here we have highlighted the
importance of studying multiple strains of rotavirus to
investigate the whole range of receptors used.
t
g
t
a
u
T
I
f
m
l
a
w
A
G
j
c
f
l
U
s
t
a
t
c
m
v
m
H
C
b
e
5
V
(
p
T
t
s
b
m
f
t
C
e
r
3
5
G
c
f
G
s
t
T
95GALACTOSE AND ROTAVIRUS RECEPTORSMATERIALS AND METHODS
Cells and viruses
Simian SA11 and bovine NCDV Lincoln rotaviruses
were obtained from Dr. H. Malherbe and Dr. H. Green-
berg, respectively. Porcine CRW8 was isolated in this
laboratory and kindly provided by Dr. H. Nagesha and Dr.
J. Huang. Human strain Wa was originally isolated by Dr.
R. Wyatt and provided by Dr. R. F. Bishop of the Royal
Children’s Hospital, Melbourne, Australia. Influenza
strains A/Brazil/11/78 (H1N1) and Mem71H-BelN (H3N1),
a reassortant with the hemagglutinin of A/Memphis/1/71
(H3N2), and the neuraminidase of A/Bel/42 (H1N1) were
provided by Dr. E. M. Anders, Department of Microbiol-
ogy and Immunology, University of Melbourne, Australia.
All rotaviruses were activated with 10 mg/ml porcine
rypsin type IX (Sigma) for 30 min at 37°C and propa-
ated in MA104 cells in the presence of 0.5 mg/ml trypsin
as described previously (Huang et al., 1992). When in-
fected cells showed 80% cytopathic effect, virus was
harvested by freeze–thawing twice and infected lysate
was stored at 270°C.
To obtain purified triple-shelled particles, cell lysates
were prepared as described above except MA104 cells
were grown on Cytodex 3 beads (Amersham, Uppsala,
Sweden) in Techne 500-ml spinner flasks. After two
rounds of freeze–thawing infected lysate was treated
with 25% (v/v) Arklone P (ICI), homogenized in a blender
for 1 min, and subjected to low-speed centrifugation to
remove cell debris and beads. Virus from the aqueous
phase was pelleted in a SW28 ultracentrifuge rotor
(Beckman) at 100,000 g for 75 min. Viral pellets were then
resuspended in Tris–saline with calcium (TSC) (50 mM
Tris, 20 mM NaCl, 100 mM CaCl2, pH 7.2), loaded on
30–60% v/v glycerol gradients, and centrifuged in a SW41
rotor for 75 min at 100,000 g. Visible bands containing
riple-shelled particles were removed from the gradient
nd resuspended in TSC and concentrated again by
ltracentrifugation. Pelleted virus was resuspended in
SC and stored at 270°C.
nfectivity and lectin inhibition assays
Infectivity assays to determine virus titers were per-
ormed as described previously (Beards et al., 1980) with
odifications (Lazdins et al., 1995). For inhibition assays
ectins from A. precatorius, Artocarpus integrifolia, Ma.
murensis, Maclura pomifera, Mo. charantia, and S. nigra
ere obtained from EY Laboratories Inc., San Mateo, CA.
rachis hypogaea, Bauhinia purpurea, Datura stramonium,
lycine max, Limulus polyphemus, R. communis, Sophora
aponica, Triticum vulgaris, and V. album lectins were pur-
hased from Sigma Chemical Co. (St. Louis, MO). Limax
lavus lectin was from Calbiochem, La Jolla, CA and the
ectin from Tridacna maxima was a gift from Brian Baldo,
niversity of Western Australia, Perth. Briefly, lectins were
a
ferially diluted in virus diluent (Hanks’ balanced salt solu-
ion containing 0.002% gelatin and 0.01 M HEPES, pH 7.5)
nd incubated on confluent MA104 cells in NUNC 96-well
rays for 15 min at 4°C. Following this time virus diluted to
ontain 200–400 fluorescent foci/well was added and this
ixture was incubated on cells for a further hour. The
irus–lectin mixture was then removed and replaced with
aintenance medium (MEM supplemented with 20 mM
EPES) and incubated in a humidified environment with 5%
O2 for 16 h at 37°C. Detection of virus infected cells was
y indirect immunofluorescence. The inhibitory titer was
xpressed as the highest concentration of lectin causing a
0% reduction in fluorescent foci compared to the control.
irus overlay protein blot assay
VOPBAs were performed as described previously
Beisner et al., 1998). Briefly, MA104 cell proteins were
solubilized (Verdin et al., 1989) and separated on a 10%
SDS–PAGE gel under reducing conditions. Proteins were
electrophoretically transferred to nitrocellulose for 1 h at
100 V in a Bio-Rad apparatus. After being blocked for 3 h
in 5% skim milk (5% gelatin was used for the Ricinus
lectin–SA11 competition VOPBA), blots were incubated
for 16 h at room temperature with either 3–5 mg/ml of
urified triple-shelled SA11, NCDV, Wa, or CRW8 virus in
SC 1 0.1% Tween 20 (TSC-T) or SA11 with 15 mg/ml
Ricinus agglutinin lectin (RCA120). Bound virus was de-
ected using hyperimmune rabbit anti-SA11 or CRW8
erum or anti-NCDV or Wa mouse ascites fluid followed
y HRP-conjugated sheep anti-rabbit or anti-mouse im-
unoglobulin (Silenus). Color development was per-
ormed using diaminobenzidine with 4-chloro-1-naph-
hol.
onstruction of ricin single binding domain
xpressing phage
The plasmid pSP64TpRB containing the B subunit of
icin (RCA60) (a gift from Professor M. J. Lord, Department
of Biological Sciences, University of Warwick, England)
was used for PCR amplification of SBD1 (aa 1–143) and
SBD2 (aa 135–262) of the ricin toxin B subunit. For am-
plification of SBD1 59 CGCTGATGTTTGTATGGATCCTG 39
(forward primer) and 59 CGGTTGTAACAAAAGGTTGTGTA
9 (reverse primer) were used. SBD2 amplification used
9 GCAATAATACACAACCTTTT 39 (forward primer) and 59
AAATAATGGTAACCATATTTGGT 39 (reverse primer). For
onstruction of the SBD2 mutant SBD2His248 a longer
orward primer was used: 59 CAATAATACACAACCTTTT-
TTACAACCATTGTTGG 39. The reverse primer contained a
ingle base change to encode a histidine rather than a
yrosine at amino acid 248: 59 GAAATAATGGTAACCATATT-
GGTTTGGGTCACCATGGAGAGGGTGAAGAA 39.
PCR products were blunt ended with T4 polymerase
nd ligated into Gene 3 of the Fuse1 phage vector (a gift
rom Professor G. P. Smith, Division of Biological Sci-
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digested with PvuII and dephosphorylated with alkaline
phosphatase. The ligation mix was electroporated into
fresh MC1061 cells and amplification and purification of
recombinant bacteriophage were performed as de-
scribed (Smith, 1985; Smith and Scott, 1993).
Enzyme immunoassay to measure binding (lectin)
activity of recombinant phage
Lectin activity of purified R. agglutinin and recombi-
nant bacteriophage expressing SBD1, SBD2, or
SBD2His248 was measured by binding to asialofetuin in
an EIA exactly as described by Swimmer et al. (1992).
However, for the detection of recombinant phage, rabbit
anti-fd antibody (Sigma) rather than anti-M13 antibody
was used.
SBD1 and SBD2 phage inhibition assays
Assays for SBD1, SBD2, and SBD2His248 inhibition of
rotavirus infection of MA104 cells were similar to those
described above for complete lectins. Recombinant
phage was diluted in Tris-buffered saline (TBS) and 50-ml
aliquots were incubated on MA104 cells in a 96-well
microtiter tray for an hour at 4°C. After this virus diluted
to contain 200–400 fluorescent focus forming units (FFU)
in 50 ml was added and incubated for a further hour.
Virus–phage mixtures were then removed and replaced
with maintenance medium and plates were incubated in
a humidified environment with 5% CO2 for 16 h. Virus
infected cells were then detected by indirect immunoflu-
orescence.
Phage inhibition of rotavirus binding to MA104 cells
was measured as follows. Recombinant phage was di-
luted in ice-cold TBS and incubated on cells for an hour
at 4°C followed by the addition of ice-cold diluted virus
(200–400 FFU in 50 ml) which was allowed to adsorb for
further hour at 4°C. Unbound virus was then removed
y aspiration and cells were washed in ice-cold phos-
hate-buffered saline. Cell-bound virus was harvested by
reeze–thawing at 270°C and treated with porcine tryp-
in to liberate any remaining cell receptor-associated
irus. Virus was then titrated using the standard rotavirus
nfectivity assay and the percentage virus bound com-
ared to the non-phage-treated control was determined.
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